Anteis in brief and figures

• One of the worldwide actors in the area of injectable medical devices based on biopolymer transformation
• Creation: March 2003
• CEO: Gilles Bos
• Activity sectors: ophthalmology, orthopaedics and aesthetic dermatology
• Present in over 90 countries in aesthetic dermatology, on 5 continents
• Three subsidiaries: in France, Germany and Japan
• Total staff: 150 employees
• A licensing agreement with the German group: Merz Pharmaceutical
• Four patents filed in the biopolymer transformation field
• 15% of annual revenue dedicated to research and development
• 2 laboratories
  
• Exponential sales

Anteis

• Newsfeed
• Swiss precision and technology
• A vocation, a vision
• Our values
• A word from the CEO, Gilles Bos
• The Anteis Team
• In brief and figures
• A worldwide success, supporting proof
• Awards
• Partnerships
• Glossary
• Trademarks